当前位置:首页 - 行情中心 - 威尔药业(603351) - 财务分析 - 现金流量表

威尔药业

(603351)

  

流通市值:38.03亿  总市值:38.03亿
流通股本:1.35亿   总股本:1.35亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金526,557,305.31262,108,818.881,077,385,182.45825,180,131.23
  收到的税费返还7,878,432.14,621,662.0513,357,336.112,321,553.95
  收到其他与经营活动有关的现金5,864,565.041,946,650.198,938,195.755,282,489.64
  经营活动现金流入小计540,300,302.45268,677,131.121,099,680,714.3842,784,174.82
  购买商品、接受劳务支付的现金308,224,270.74165,576,856.45581,184,961.33476,681,445.37
  支付给职工以及为职工支付的现金82,961,898.8755,445,080.19136,688,805.45105,530,793.94
  支付的各项税费36,731,084.2914,492,378.7983,448,734.1664,488,832.64
  支付其他与经营活动有关的现金38,108,431.1310,951,359.7976,564,767.934,877,916.55
  经营活动现金流出小计466,025,685.03246,465,675.22877,887,268.84681,578,988.5
  经营活动产生的现金流量净额74,274,617.4222,211,455.9221,793,445.46161,205,186.32
二、投资活动产生的现金流量:
  收回投资收到的现金--9,273,208.548,069,933.36
  取得投资收益收到的现金--203,760-
  收到的其他与投资活动有关的现金900,000900,000500,000500,000
  投资活动现金流入小计900,000900,0009,976,968.548,569,933.36
  购建固定资产、无形资产和其他长期资产支付的现金39,197,235.0819,925,198.8351,457,885.143,475,153.98
  投资支付的现金33,000,00030,000,00027,800,00029,200,000
  支付其他与投资活动有关的现金600,000600,0001,200,0001,400,000
  投资活动现金流出小计72,797,235.0850,525,198.8380,457,885.174,075,153.98
  投资活动产生的现金流量净额-71,897,235.08-49,625,198.83-70,480,916.56-65,505,220.62
三、筹资活动产生的现金流量:
  取得借款收到的现金309,000,000121,000,000381,020,400242,886,361.11
  筹资活动现金流入小计309,000,000121,000,000381,020,400242,886,361.11
  偿还债务支付的现金239,800,00091,300,000378,300,000268,300,000
  分配股利、利润或偿付利息支付的现金60,027,865.222,757,064.0955,466,885.3650,820,541.34
  支付其他与筹资活动有关的现金4,825,434.933,338,664.0810,285,349.437,782,488.74
  筹资活动现金流出小计304,653,300.1597,395,728.17444,052,234.79326,903,030.08
  筹资活动产生的现金流量净额4,346,699.8523,604,271.83-63,031,834.79-84,016,668.97
四、汇率变动对现金及现金等价物的影响342,762.81-2,456.451,373,441.63636,376.69
五、现金及现金等价物净增加额7,066,845-3,811,927.5589,654,135.7412,319,673.42
  加:期初现金及现金等价物余额247,200,482.38247,200,482.38157,546,346.64157,546,346.64
  期末现金及现金等价物余额254,267,327.38243,388,554.83247,200,482.38169,866,020.06
补充资料:
  净利润71,302,630.46-145,205,838.7-
  资产减值准备2,467,637.19-9,014,547.81-
  固定资产和投资性房地产折旧59,616,498.13-102,706,888.04-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧59,616,498.13-102,706,888.04-
  无形资产摊销2,423,086.46-4,659,431.49-
  长期待摊费用摊销36,334.29-86,969.87-
  处置固定资产、无形资产和其他长期资产的损失-6,484.57---
  固定资产报废损失90,420.98-168,218.5-
  公允价值变动损失-1,736.22--12,072,961.13-
  财务费用5,613,022.4-12,464,017.03-
  投资损失--68,939.98-
  递延所得税949,858.45-5,088,725.2-
  其中:递延所得税资产减少451,587.74-1,170,114.06-
    递延所得税负债增加498,270.71-3,918,611.14-
  存货的减少-11,785,019.22--40,461,738.19-
  经营性应收项目的减少-78,285,739.97--13,566,041.63-
  经营性应付项目的增加16,663,396.16--3,983,056.8-
  其他--3,357,643.89-
  不涉及现金收支的投资和筹资活动金额其他项目--24,771,652.06-
  现金的期末余额254,267,327.38-247,200,482.38-
  减:现金的期初余额247,200,482.38-157,546,346.64-
  现金及现金等价物的净增加额7,066,845-89,654,135.74-
公告日期2025-08-202025-04-222025-04-222024-10-24
审计意见(境内)标准无保留意见
TOP↑